Steven D. Harr's most recent trade in Sana Biotechnology Inc was a trade of 750,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 6, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sana Biotechnology Inc | Steven D. Harr | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 750,000 | 750,000 | - | - | Stock Option (Right to Buy) | |
| Sana Biotechnology Inc | Steven D. Harr | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 166,667 | 166,667 | - | - | Restricted Stock Units | |
| Sana Biotechnology Inc | Steven D. Harr | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 50,000 | 150,000 | - | - | Restricted Stock Units | |
| Sana Biotechnology Inc | Steven D. Harr | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 50,000 | 7,889,750 | - | 0 | Common Stock | |
| Sana Biotechnology Inc | Steven D. Harr | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.56 per share. | 06 Mar 2025 | 12,820 | 7,876,930 | - | 2.6 | 32,819 | Common Stock |
| Sana Biotechnology Inc | Steven D. Harr | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 900,000 | 900,000 | - | - | Stock Option (Right to Buy) | |
| Sana Biotechnology Inc | Steven D. Harr | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 200,000 | 200,000 | - | - | Restricted Stock Units | |
| Sana Biotechnology Inc | Steven D. Harr | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 650,000 | 650,000 | - | - | Stock Options (Right to Buy) | |
| Sana Biotechnology Inc | Steven D. Harr | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 760,000 | 760,000 | - | - | Stock Options (Right to Buy) | |
| Sana Biotechnology Inc | Steven D. Harr | Director, President & CEO | 08 Feb 2021 | 2,031,250 | 8,173,750 | - | - | Common Stock | ||
| Sana Biotechnology Inc | Steven D. Harr | Director, President & CEO | 08 Feb 2021 | 1,075,000 | 0 | - | - | Series A-1 Convertible Preferred Stock | ||
| Sana Biotechnology Inc | Steven D. Harr | Director, President & CEO | 08 Feb 2021 | 800,000 | 0 | - | - | Series A-2 Convertible Preferred Stock | ||
| Sana Biotechnology Inc | Steven D. Harr | Director, President & CEO | 08 Feb 2021 | 156,250 | 0 | - | - | Series B Convertible Preferred Stock |